TickerFacts.

TransMedics Group, Inc. (TMDX): Revenue

Annual figures by period end, from SEC filings.

$605.49M
Year ended 2025-12-31
$668.47M
Trailing 12 months to 2026-06-30
+86.4%
3-year compound annual growth
+88.2%
5-year compound annual growth
2018-12-29: $13.02M2019-12-28: $23.60M2020-12-31: $25.64M2021-12-31: $30.26M2022-12-31: $93.46M2023-12-31: $241.62M2024-12-31: $441.54M2025-12-31: $605.49M$605.49M
2018-12-29 Revenue (USD) 2025-12-31
Period endedRevenueChange YoYSource filing
2025-12-31$605.49M+37.1%2026-02-24, From 2025-01-01
2024-12-31$441.54M+82.7%2026-02-24, From 2024-01-01
2023-12-31$241.62M+158.5%2026-02-24, From 2023-01-01
2022-12-31$93.46M+208.8%2025-02-27, From 2022-01-01
2021-12-31$30.26M+18.0%2024-02-27, From 2021-01-01
2020-12-31$25.64M+8.6%2023-02-27, From 2019-12-29
2019-12-28$23.60M+81.3%2021-03-11, From 2018-12-30
2018-12-29$13.02Mn/a2020-03-17, From 2017-12-31

Revenue at similar companies

Companies with the same SEC industry code (Electromedical & Electrotherapeutic Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedRevenueChange YoY
TransMedics Group, Inc. (TMDX)2025-12-31$605.49M+37.1%
InMode Ltd. (INMD)2025-12-31$370.50M-6.2%
Conmed Corp (CNMD)2025-12-31$1.37B+5.2%
LivaNova PLC (LIVN)2025-12-31$1.39B+10.7%
Axogen, Inc. (AXGN)2025-12-31$225.21M+20.2%
Integer Holdings Corp (ITGR)2025-12-31$1.85B+8.0%
Outset Medical, Inc. (OM)2025-12-31$119.48M+5.1%
Biolife Solutions Inc (BLFS)2025-12-31$96.21M+28.9%
Vaso Corp (VASO)2025-12-31$89.10M+2.7%

Compare TMDX, INMD, CNMD, LIVN side by side · Screen every company in Electromedical & Electrotherapeutic Apparatus ↗